Cargando...
SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
Type 2 diabetes mellitus is a chronic metabolic disease associated with high cardiovascular (CV) risk. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are the latest class of antidiabetic medication that inhibit the absorption of glucose from the proximal tubule of the kidney and hence cause gly...
Guardado en:
| Publicado en: | Int J Environ Res Public Health |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6720282/ https://ncbi.nlm.nih.gov/pubmed/31426529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijerph16162965 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|